Avenue Pierre Brossolette, 1

91385, Chilly-Mazarin

FRANCE

 

sanofi.com

 

Project leader

 
Dr. Cecile Orsini
 
Phone +33 1 58 93 31 30
E-Mail  

Project staff

 
Dr. Andreas Czich
 
Phone +49 69 305 20710
E-Mail  

 

 
Dr. Jean-Michel Guillon
 
Phone +33 1 58 93 85 59
E-Mail  

 

 
Dr. Gilles Labbe
 
Phone +33 1 58 93 35 27
E-Mail  

 

 
Dr. Jean-Pierre Martinolle
 
Phone +33 4 99 77 60 49
E-Mail  

 

 
Dr. Marie-Christine Multon
 
Phone +33 1 58 93 34 770
E-Mail  

 

 
Dr. Michel Partiseti
 
Phone +33 1 58 93 29 96
E-Mail  

 

 
Dr. Emmanuel Spanakis
 
Phone +33 1 58 93 34 35
E-Mail  

 

 
Laurence Mazuranok
 
Phone +33 426 23 23 80
E-Mail  

 


Institute presentation

Within the SANOFI pharmaceutical group, Sanofi-Aventis Recherche & Developpement (SARD) focuses on finding innovative solutions to major public health challenges and to patients’ needs.
The group concentrates its efforts on several major priorities including diabetes, oncology, ophthalmology, infectious diseases, aging, neurodegenerative diseases, immuno-inflammation, fibrosis and tissue repair. Sanofi-Aventis Recherche & Developpement (SARD) through three departments (Global Biotherapeutics, DSAR: Disposition, Safety & Animal Research and LGCR: Lead Generation to Candidate Realization) is involved in StemBANCC in 7 work-packages out of 12.